Post-approval studies (Phase 4)WithdrawnNCT01878318
What this trial is testing
The Effect of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate on Articular Damage in The Hand in Patients With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response to Non-Biological DMARDs
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche